UncategorizedCyclarity Therapeutics receives approval for human clinical trial Empower Meds / November 25, 2025
UncategorizedPersonalized approach to muscle regeneration holds promise for longevity Empower Meds / November 25, 2025
UncategorizedNext Health opens first of four Nashville clinics in The Gulch – Longevity.Technology Empower Meds / November 25, 2025
UncategorizedVitalia founders announce separate projects focused on innovation Empower Meds / November 25, 2025
UncategorizedTenvie launches with $200m to combat age-related diseases Empower Meds / November 25, 2025
UncategorizedImmunis secures $25M to advance Phase 2 trials – Longevity.Technology Empower Meds / November 25, 2025
UncategorizedHuman Longevity Inc. and SleepScore Labs launch AI sleep program – Longevity.Technology Empower Meds / November 25, 2025
UncategorizedInsilico licenses AI-discovered drug candidate to Menarini Empower Meds / November 25, 2025
UncategorizedTune dials-in $175m to advance epigenetic editing therapies Empower Meds / November 25, 2025
